NO20092832L - Fremgangsmate for karbonylering av en forbindelse - Google Patents

Fremgangsmate for karbonylering av en forbindelse

Info

Publication number
NO20092832L
NO20092832L NO20092832A NO20092832A NO20092832L NO 20092832 L NO20092832 L NO 20092832L NO 20092832 A NO20092832 A NO 20092832A NO 20092832 A NO20092832 A NO 20092832A NO 20092832 L NO20092832 L NO 20092832L
Authority
NO
Norway
Prior art keywords
hydrogen atom
represent
atom
present
vitamin
Prior art date
Application number
NO20092832A
Other languages
English (en)
Other versions
NO332310B1 (no
Inventor
Takashi Emura
Akira Kawase
Kazumi Morikawa
Masayuki Ohmori
Kazuki Shimizu
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20092832L publication Critical patent/NO20092832L/no
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of NO332310B1 publication Critical patent/NO332310B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

hvori R12 og R13 hver representerer en beskyttelsesgruppe, og R14 representerer en utgående gruppe, i et løsningsmiddel i nærvær av en organoaluminiumreagens og en palladiumkatalysator under en karbonmonoksydatmosfære til å fremstille en forbindelse med formel (3): hvori R12 og R13 er som definert overfor og R15 representerer en alkylgruppe, en arylgruppe, en alkenylgruppe eller en alkynylgruppe.
NO20092832A 2000-06-15 2009-08-13 Fremgangsmate for karbonylering av en forbindelse NO332310B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000179251 2000-06-15
JP2000351412 2000-11-17
JP2000375024 2000-12-08
PCT/JP2001/005062 WO2001096293A1 (en) 2000-06-15 2001-06-14 Vitamin d derivatives

Publications (2)

Publication Number Publication Date
NO20092832L true NO20092832L (no) 2003-02-17
NO332310B1 NO332310B1 (no) 2012-08-20

Family

ID=27343730

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20026014A NO328868B1 (no) 2000-06-15 2002-12-13 Vitamin D-derivat, anvendelse derav, og farmasoytisk preparat og terapeutisk middel for hudsykdommer omfattende et slikt derivat
NO20092832A NO332310B1 (no) 2000-06-15 2009-08-13 Fremgangsmate for karbonylering av en forbindelse

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO20026014A NO328868B1 (no) 2000-06-15 2002-12-13 Vitamin D-derivat, anvendelse derav, og farmasoytisk preparat og terapeutisk middel for hudsykdommer omfattende et slikt derivat

Country Status (15)

Country Link
US (1) US7985744B2 (no)
EP (1) EP1295871B1 (no)
JP (2) JP3706104B2 (no)
KR (2) KR100734799B1 (no)
CN (2) CN100469764C (no)
AT (1) ATE509910T1 (no)
AU (2) AU6428001A (no)
CA (2) CA2411409C (no)
DK (1) DK1295871T3 (no)
HK (1) HK1054373B (no)
IL (3) IL153395A0 (no)
NO (2) NO328868B1 (no)
NZ (1) NZ528622A (no)
TW (1) TWI288131B (no)
WO (1) WO2001096293A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6242434B1 (en) * 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US20020128240A1 (en) * 1996-12-30 2002-09-12 Bone Care International, Inc. Treatment of hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) * 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6087350A (en) * 1997-08-29 2000-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
JP2004504295A (ja) 2000-07-18 2004-02-12 ボーン　ケア　インターナショナル　インコーポレイテッド 安定化１α−ヒドロキシビタミンＤ
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
EP1829860A4 (en) * 2004-12-03 2011-06-08 Nippon Shinyaku Co Ltd 9,10-SECOPREGNANDERIVAT AND MEDICINE
WO2006093291A1 (ja) * 2005-03-04 2006-09-08 Tokyo Medical And Dental University １９－ノルビタミンｄ誘導体
JP5095413B2 (ja) * 2005-11-30 2012-12-12 中外製薬株式会社 光反応を用いるビタミンｄ誘導体の製法
JP5248115B2 (ja) * 2005-12-02 2013-07-31 中外製薬株式会社 コンバージェント法を用いるビタミンｄ誘導体の製造方法
KR20160112018A (ko) * 2006-06-02 2016-09-27 니뽄 신야쿠 가부시키가이샤 9,10-세코프레그난 유도체 및 의약
WO2008131267A2 (en) * 2007-04-18 2008-10-30 Johns Hopkins University Low calcemic, highly antiproliferative, analogs of calcitriol
US8551463B2 (en) 2007-10-22 2013-10-08 Living Proof, Inc. Hair care compositions and methods of treating hair
DE102009028939A1 (de) * 2009-08-27 2011-03-03 Ludwig-Maximilians-Universität München Verfahren zur Herstellung von Arylaluminiumhalogeniden und deren Verwendung
JP5652723B2 (ja) * 2012-08-17 2015-01-14 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトールの新しい結晶形態
CN106279239B (zh) * 2015-05-29 2019-06-28 上海彩迩文生化科技有限公司 多烯化合物、制备方法及其应用
US10548908B2 (en) * 2016-09-15 2020-02-04 Nostopharma, LLC Compositions and methods for preventing and treating heterotopic ossification and pathologic calcification
CN113105517B (zh) * 2021-04-10 2022-03-01 台州仙琚药业有限公司 雄甾-1,4,9-三烯-3,17-二酮的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666634A (en) * 1984-12-05 1987-05-19 Chugai Seiyaku Kabushiki Kaisha vitamin D3 derivatives having a substituent at 2-position
PL171580B1 (pl) * 1991-11-07 1997-05-30 Res Inst Medicine Chem Sposób wytwarzania nowych analogów witaminy D3 PL PL PL
JP3493037B2 (ja) * 1991-12-18 2004-02-03 中外製薬株式会社 ２２−オキサコレカルシフェロール誘導体とその製造方法
GB9226877D0 (en) * 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Chemical compounds
GB9309422D0 (en) * 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
US5361722A (en) 1993-06-16 1994-11-08 Universal Dairy Equipment Inc. Milking facility with service alley
JP3759639B2 (ja) 1994-04-11 2006-03-29 中外製薬株式会社 ２２−チアビタミン▲ｄ３▼誘導体
WO1995027697A1 (en) * 1994-04-11 1995-10-19 Chugai Seiyaku Kabushiki Kaisha 22-thiavitamin d3 derivative
PE28297A1 (es) * 1995-01-26 1997-08-20 Hoffmann La Roche Empleo dermatologico de derivados de vitamina d
JP4012293B2 (ja) 1996-12-20 2007-11-21 中外製薬株式会社 １６−エン−ビタミンｄ誘導体
US6184398B1 (en) 1996-12-20 2001-02-06 Chugai Seiyaku Kabushiki Kaisha 16-ene-vitamin D derivatives
CA2275382A1 (en) * 1996-12-20 1998-07-02 Chugai Seiyaku Kabushiki Kaisha 16-ene-vitamin d derivatives
DE69832699T2 (de) * 1997-05-16 2006-08-24 Woman & Infants Hospital Zyklische äther vitamin d3 verbindungen, 1alfa(oh) 3-epi-vitamin d3 verbindungen und deren verwendungen
JP4803939B2 (ja) * 2000-04-19 2011-10-26 中外製薬株式会社 ビタミンｄ誘導体
JP5095413B2 (ja) * 2005-11-30 2012-12-12 中外製薬株式会社 光反応を用いるビタミンｄ誘導体の製法
JP5248115B2 (ja) * 2005-12-02 2013-07-31 中外製薬株式会社 コンバージェント法を用いるビタミンｄ誘導体の製造方法

Also Published As

Publication number Publication date
US7985744B2 (en) 2011-07-26
CA2664720C (en) 2011-11-22
CN100469764C (zh) 2009-03-18
IL178350A (en) 2010-11-30
HK1054373B (en) 2011-11-18
NO20026014L (no) 2003-02-17
IL178350A0 (en) 2007-02-11
JP2005060402A (ja) 2005-03-10
DK1295871T3 (da) 2011-07-11
EP1295871A1 (en) 2003-03-26
NO20026014D0 (no) 2002-12-13
WO2001096293A1 (en) 2001-12-20
TWI288131B (en) 2007-10-11
AU2001264280B2 (en) 2005-08-25
NO332310B1 (no) 2012-08-20
IL153395A0 (en) 2003-07-06
EP1295871B1 (en) 2011-05-18
NZ528622A (en) 2005-05-27
CA2411409A1 (en) 2002-12-04
CA2664720A1 (en) 2002-12-04
CN102617690B (zh) 2015-07-08
KR100734799B1 (ko) 2007-07-03
CN1436170A (zh) 2003-08-13
EP1295871A4 (en) 2009-02-25
JP4233504B2 (ja) 2009-03-04
KR20060070581A (ko) 2006-06-23
CA2411409C (en) 2011-05-17
US20040019023A1 (en) 2004-01-29
AU6428001A (en) 2001-12-24
IL153395A (en) 2010-06-30
ATE509910T1 (de) 2011-06-15
HK1054373A1 (en) 2003-11-28
KR100786053B1 (ko) 2007-12-17
KR20030029058A (ko) 2003-04-11
CN102617690A (zh) 2012-08-01
JP3706104B2 (ja) 2005-10-12
AU2001264280C1 (en) 2001-12-24
HK1056163A1 (zh) 2004-02-06
NO328868B1 (no) 2010-06-07

Similar Documents

Publication Publication Date Title
NO20026014D0 (no) Vitamin D-derivater
NO953305D0 (no) Antranilsyrederivat
IL132522A0 (en) Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and pharmaceutical compositions containing the same
HUP0401889A2 (hu) 1,8-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények
ATE188216T1 (de) Therapeutische mittel für die parkinsonsche krankheit
DE69935718D1 (de) Antidiabetische medikamente
ATE268752T1 (de) Aralkyl-1,2-diaminen mit calcimimetischer wirkung und verfahren zu ihrer herstellung
ES2096073T3 (es) Derivado de benzamida.
ATE206926T1 (de) Verwendung eines phosphorsäurediesters zur herstellung eines arzneimittels zur behandlung von akne
ATE223411T1 (de) 1-methylcarbapenem-derivate
ATE196080T1 (de) Verwendung von diphenylethanderivaten zur herstellung eines arzneimittels zur behandlung von glaukom
PT805155E (pt) Novo composto heterociclico condensado, anti-oxidante triciclico
FI944207A0 (fi) Cyclohexane derivatives
ATE278701T1 (de) Malto-oligosaccharide und deren verwendung
DE69305684D1 (de) Octahydronaphthalenoxim Derivate für die Inhibierung der Cholesterin Biosynthese, ihre Herstellung und Verwendung
ATE275560T1 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
NO20004798L (no) Barbitursyrederivat og forebyggende og terapeutisk middel for ben og brusk inneholdende det samme
DK1614684T3 (da) Diaminderivat, produktionsproces og antioxidantlægemiddel
ATE420855T1 (de) 2-substituierte vitamin-d-derivate

Legal Events

Date Code Title Description
MK1K Patent expired